Artificial Intelligence in Healthcare
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
“With high skilled talent,
technology, vast data availability, and the potential for population-scale AI
adoption, India has a tremendous opportunity to lead human-centric applications
and democratise AI for the world,” says Prakash Mallya, vice-president and
managing director of Intel India's Sales, Marketing, and Communications Group.
Intel has been concentrating its efforts
on speeding AI innovation in order to offer transformational healthcare
solutions and democratise access to and delivery of healthcare in India. Some
of the most intriguing healthcare and life sciences applications are powered by
the company's portfolio of computing, memory, storage, and networking
technology.
Netra is a cloud-based AI system. AI
is the most recent illustration of the influence and innovation that Intel
technology can provide. Deep learning is used to diagnose retinal problems in a
short amount of time with the same degree of accuracy as human doctors.
Intel Xeon Scalable CPUs with Intel
Deep Learning Boost and Intel Advanced Vector Extension 512 acceleration are
supported by Netra.AI. The Intel architecture provides robust data security,
quick processing of huge data quantities, and service flexibility. To improve
application performance, the solution includes access to Intel-optimized images
for TensorFlow, Apache MXNet, and PyTorch, as well as Intel performance
libraries.
Ophthalmologists and retinal
surgeons are not replaced by this approach. “AI and technology are
democratising healthcare access, particularly in the area of disease detection.
Our team at the Sankara Eye Foundation has been working hard to achieve our
goal of eliminating unnecessary blindness in India. The current solution,
Netra.AI, which we helped design and build with Leben Care, makes advantage of
Intel's powerful AI-enabled platforms. According to Kaushik Murali, president
of Sankara Eye Foundation India's Medical Administration, Quality &
Education, "it is an example of how likeminded partners may produce
significant and effective answers for diverse issues that mankind faces."
Netra. According to Intel experts,
AI is a great tool for detecting retinal diseases in huge populations with
limited infrastructure, resources, and an overwhelmed healthcare system. For
detecting any DR, the solution has good sensitivity and specificity, with 99.7%
and 98.5 percent, respectively. It has been shown in India as well as other Asian
and African nations.
Sankara Eye Foundation and Leben
Care are implementing Netra.AI, a cloud-based AI system powered by Intel
technology, to detect retinal diseases in a short amount of time with the same
degree of accuracy as human doctors.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
“With high skilled talent,
technology, vast data availability, and the potential for population-scale AI
adoption, India has a tremendous opportunity to lead human-centric applications
and democratise AI for the world,” says Prakash Mallya, vice-president and
managing director of Intel India's Sales, Marketing, and Communications Group.
Intel has been concentrating its efforts
on speeding AI innovation in order to offer transformational healthcare
solutions and democratise access to and delivery of healthcare in India. Some
of the most intriguing healthcare and life sciences applications are powered by
the company's portfolio of computing, memory, storage, and networking
technology.
Netra is a cloud-based AI system. AI
is the most recent illustration of the influence and innovation that Intel
technology can provide. Deep learning is used to diagnose retinal problems in a
short amount of time with the same degree of accuracy as human doctors.
Intel Xeon Scalable CPUs with Intel
Deep Learning Boost and Intel Advanced Vector Extension 512 acceleration are
supported by Netra.AI. The Intel architecture provides robust data security,
quick processing of huge data quantities, and service flexibility. To improve
application performance, the solution includes access to Intel-optimized images
for TensorFlow, Apache MXNet, and PyTorch, as well as Intel performance
libraries.
Ophthalmologists and retinal
surgeons are not replaced by this approach. “AI and technology are
democratising healthcare access, particularly in the area of disease detection.
Our team at the Sankara Eye Foundation has been working hard to achieve our
goal of eliminating unnecessary blindness in India. The current solution,
Netra.AI, which we helped design and build with Leben Care, makes advantage of
Intel's powerful AI-enabled platforms. According to Kaushik Murali, president
of Sankara Eye Foundation India's Medical Administration, Quality &
Education, "it is an example of how likeminded partners may produce
significant and effective answers for diverse issues that mankind faces."
Netra. According to Intel experts,
AI is a great tool for detecting retinal diseases in huge populations with
limited infrastructure, resources, and an overwhelmed healthcare system. For
detecting any DR, the solution has good sensitivity and specificity, with 99.7%
and 98.5 percent, respectively. It has been shown in India as well as other Asian
and African nations.
Sankara Eye Foundation and Leben
Care are implementing Netra.AI, a cloud-based AI system powered by Intel
technology, to detect retinal diseases in a short amount of time with the same
degree of accuracy as human doctors.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
“With high skilled talent,
technology, vast data availability, and the potential for population-scale AI
adoption, India has a tremendous opportunity to lead human-centric applications
and democratise AI for the world,” says Prakash Mallya, vice-president and
managing director of Intel India's Sales, Marketing, and Communications Group.
Intel has been concentrating its efforts
on speeding AI innovation in order to offer transformational healthcare
solutions and democratise access to and delivery of healthcare in India. Some
of the most intriguing healthcare and life sciences applications are powered by
the company's portfolio of computing, memory, storage, and networking
technology.
Netra is a cloud-based AI system. AI
is the most recent illustration of the influence and innovation that Intel
technology can provide. Deep learning is used to diagnose retinal problems in a
short amount of time with the same degree of accuracy as human doctors.
Intel Xeon Scalable CPUs with Intel
Deep Learning Boost and Intel Advanced Vector Extension 512 acceleration are
supported by Netra.AI. The Intel architecture provides robust data security,
quick processing of huge data quantities, and service flexibility. To improve
application performance, the solution includes access to Intel-optimized images
for TensorFlow, Apache MXNet, and PyTorch, as well as Intel performance
libraries.
Ophthalmologists and retinal
surgeons are not replaced by this approach. “AI and technology are
democratising healthcare access, particularly in the area of disease detection.
Our team at the Sankara Eye Foundation has been working hard to achieve our
goal of eliminating unnecessary blindness in India. The current solution,
Netra.AI, which we helped design and build with Leben Care, makes advantage of
Intel's powerful AI-enabled platforms. According to Kaushik Murali, president
of Sankara Eye Foundation India's Medical Administration, Quality &
Education, "it is an example of how likeminded partners may produce
significant and effective answers for diverse issues that mankind faces."
Netra. According to Intel experts,
AI is a great tool for detecting retinal diseases in huge populations with
limited infrastructure, resources, and an overwhelmed healthcare system. For
detecting any DR, the solution has good sensitivity and specificity, with 99.7%
and 98.5 percent, respectively. It has been shown in India as well as other Asian
and African nations.
Artificial Intelligence in Healthcare: An Intel AI tool checks for
eyesight loss in patients.
Sankara Eye Foundation and Leben
Care are implementing Netra.AI, a cloud-based AI system powered by Intel
technology, to detect retinal diseases in a short amount of time with the same
degree of accuracy as human doctors.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
The system may be expanded to
include additional retinal diseases and glaucoma, allowing healthcare providers
to focus their resources on individuals who require immediate attention and
treatment.
“With high skilled talent,
technology, vast data availability, and the potential for population-scale AI
adoption, India has a tremendous opportunity to lead human-centric applications
and democratise AI for the world,” says Prakash Mallya, vice-president and
managing director of Intel India's Sales, Marketing, and Communications Group.
Intel has been concentrating its efforts
on speeding AI innovation in order to offer transformational healthcare
solutions and democratise access to and delivery of healthcare in India. Some
of the most intriguing healthcare and life sciences applications are powered by
the company's portfolio of computing, memory, storage, and networking
technology.
Netra is a cloud-based AI system. AI
is the most recent illustration of the influence and innovation that Intel
technology can provide. Deep learning is used to diagnose retinal problems in a
short amount of time with the same degree of accuracy as human doctors.
Intel Xeon Scalable CPUs with Intel
Deep Learning Boost and Intel Advanced Vector Extension 512 acceleration are
supported by Netra.AI. The Intel architecture provides robust data security,
quick processing of huge data quantities, and service flexibility. To improve
application performance, the solution includes access to Intel-optimized images
for TensorFlow, Apache MXNet, and PyTorch, as well as Intel performance
libraries.
Ophthalmologists and retinal
surgeons are not replaced by this approach. “AI and technology are
democratising healthcare access, particularly in the area of disease detection.
Our team at the Sankara Eye Foundation has been working hard to achieve our
goal of eliminating unnecessary blindness in India. The current solution,
Netra.AI, which we helped design and build with Leben Care, makes advantage of
Intel's powerful AI-enabled platforms. According to Kaushik Murali, president
of Sankara Eye Foundation India's Medical Administration, Quality &
Education, "it is an example of how likeminded partners may produce
significant and effective answers for diverse issues that mankind faces."
Netra. According to Intel experts,
AI is a great tool for detecting retinal diseases in huge populations with
limited infrastructure, resources, and an overwhelmed healthcare system. For
detecting any DR, the solution has good sensitivity and specificity, with 99.7%
and 98.5 percent, respectively. It has been shown in India as well as other Asian
and African nations.
0 Comments